These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 15281910

  • 21. Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches.
    Wittke S, Mischak H, Walden M, Kolch W, Rädler T, Wiedemann K.
    Electrophoresis; 2005 Apr; 26(7-8):1476-87. PubMed ID: 15765478
    [Abstract] [Full Text] [Related]

  • 22. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
    Lapolla A, Molin L, Sechi A, Cosma C, Ragazzi E, Seraglia R, Traldi P.
    J Mass Spectrom; 2009 Dec; 44(12):1754-60. PubMed ID: 19852035
    [Abstract] [Full Text] [Related]

  • 23. Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.
    Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T.
    Diabetologia; 2002 Jun; 45(6):877-82. PubMed ID: 12107732
    [Abstract] [Full Text] [Related]

  • 24. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
    Cortés-Sanabria L, Martínez-Ramírez HR, Hernández JL, Rojas-Campos E, Canales-Muñoz JL, Cueto-Manzano AM.
    Rev Invest Clin; 2006 Jun; 58(3):190-7. PubMed ID: 16958293
    [Abstract] [Full Text] [Related]

  • 25. Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome.
    Cutillas PR, Norden AG, Cramer R, Burlingame AL, Unwin RJ.
    Clin Sci (Lond); 2003 May; 104(5):483-90. PubMed ID: 12529166
    [Abstract] [Full Text] [Related]

  • 26. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A, Mierzejewska-Iwanowska B, Szelachowska M, Siewko K, Nikołajuk A, Kinalska I, Górska M.
    Diabetes Metab Res Rev; 2008 May; 24(4):310-7. PubMed ID: 18273859
    [Abstract] [Full Text] [Related]

  • 27. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
    Murussi M, Gross JL, Silveiro SP.
    J Diabetes Complications; 2006 May; 20(4):210-5. PubMed ID: 16798471
    [Abstract] [Full Text] [Related]

  • 28. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 29. 'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes.
    Adetunji OR, Mani H, Olujohungbe A, Abraham KA, Gill GV.
    Diabetes Res Clin Pract; 2009 Aug; 85(2):179-82. PubMed ID: 19481284
    [Abstract] [Full Text] [Related]

  • 30. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
    Currie GE, von Scholten BJ, Mary S, Flores Guerrero JL, Lindhardt M, Reinhard H, Jacobsen PK, Mullen W, Parving HH, Mischak H, Rossing P, Delles C.
    Cardiovasc Diabetol; 2018 Apr 06; 17(1):50. PubMed ID: 29625564
    [Abstract] [Full Text] [Related]

  • 31. Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry.
    Neuhoff Nv, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A, Sundmacher A, Schlegelberger B, Kolch W, Mischak H.
    Rapid Commun Mass Spectrom; 2004 Apr 06; 18(2):149-56. PubMed ID: 14745763
    [Abstract] [Full Text] [Related]

  • 32. Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip.
    Wu J, Chen YD, Yu JK, Shi XL, Gu W.
    Diabetes Res Clin Pract; 2011 Feb 06; 91(2):213-9. PubMed ID: 21237525
    [Abstract] [Full Text] [Related]

  • 33. Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus.
    Fukui M, Shiraishi E, Tanaka M, Senmaru T, Sakabe K, Harusato I, Hasegawa G, Nakamura N.
    Metabolism; 2009 Aug 06; 58(8):1076-9. PubMed ID: 19416792
    [Abstract] [Full Text] [Related]

  • 34. [Urine proteins and excretion of brush-border antigens in the early stages of diabetic nephropathy].
    Mutti A, Ghiggeri GM, Alinovi R, Bergamaschi E, Spaggiari M, Franchini I, Queirolo C, Borghetti A.
    Ann Ital Med Int; 1988 Aug 06; 3(1):10-8. PubMed ID: 3152832
    [No Abstract] [Full Text] [Related]

  • 35. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL, Toto RD, McCullough PA.
    J Hum Hypertens; 2005 Feb 06; 19(2):139-44. PubMed ID: 15457206
    [Abstract] [Full Text] [Related]

  • 36. Capillary electrophoresis mass spectrometry as a potential tool to detect lithium-induced nephropathy: Preliminary results.
    Raedler TJ, Wittke S, Jahn H, Koessler A, Mischak H, Wiedemann K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):673-8. PubMed ID: 18155820
    [Abstract] [Full Text] [Related]

  • 37. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 01; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 38. Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.
    Zürbig P, Schiffer E, Mischak H.
    Methods Mol Biol; 2009 Aug 01; 564():105-21. PubMed ID: 19544019
    [Abstract] [Full Text] [Related]

  • 39. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
    Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H.
    Kidney Int; 2005 Jun 01; 67(6):2313-20. PubMed ID: 15882273
    [Abstract] [Full Text] [Related]

  • 40. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Jun 01; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.